title=MED-RT - Synopsis
date=2018-05-07
updated=2018-05-07
type=page
status=published
~~~~~~


<!--menu-->
<div class="row">
 <div class="container-fluid navbar navbar-default" role="navigation">
  <div class="btn-group navbar-btn visible-*" role="group">
   <a class="btn btn-md" role="button" href="index.html">Synopsis</a>
   <a class="btn btn-md" role="button" href="metadata.html">Metadata</a>
   <a class="btn btn-md" role="button" href="stats.html">Statistics</a>
   <a class="btn btn-md" role="button" href="sourcerepresentation.html">Source Representation</a>
   <a class="btn btn-md" role="button" href="metarepresentation.html">Metathesaurus Representation</a>
  </div>
 </div>
</div>
<!--endmenu-->
<br/><div id="summary">
  <p><strong>Web site:</strong><br>
    <a href="https://www.cancer.gov/research/resources/terminology/fmt" target="_blank">https://www.cancer.gov/research/resources/terminology/fmt</a></p>
  <p><strong>Authority</strong><br>
    The&nbsp;Veterans Health Administration (VHA) produces the Medical Reference Terminology (MED-RT). &nbsp;The VHA is a division of the U.S. Department of Veteran Affairs.</p>
  <p><strong>Purpose</strong><br>
    MED-RT is a replacement and successor to <a href="../NDFRT/index.html">NDF-RT</a>. &nbsp;Both terminologies are formal ontological representations of medication terminology, pharmacologic classifications, and asserted authoritative relationships between them. </p>
  <p><strong>Description</strong><br>
    MED-RT includes native pharmacologic classification concepts (e.g. mechanisms of action (MoA), physiologic effects (PE), Established Pharmacologic Class (EPC)) and all relationships asserted between concepts in any namespace. </p>
  <p>MED-RT incorporates the following terminologies:</p>
  <ul>
    <li><a href="../RXNORM/index.html">RxNorm</a> for prescribable medications, active ingredients, and relationships between them</li>
    <li><a href="../MESH/index.html">MeSH</a> for indexing chemical structure and therapeutics using its concept hierarchies</li>
    <li><a href="../SNOMEDCT_US/index.html">SNOMED CT</a> International to aid in mapping between FDA pharmacologic classes and its product and substance hierarchies</li>
  </ul>
  <p>MED-RT will maintain the pharmacologic classification relationships from NDF-RT.</p>
  <p>It also maintains the&nbsp;National Committee on Vital and Health Statistics (NCVHS) standards for describing&nbsp;medication pharmacologic classification: MoA and PE hierarchy concepts. The concepts are components of the <a href="https://www.cancer.gov/research/resources/terminology/fmt">Federal Medication Terminologies</a> (FMT) interagency collaboration.</p>
  <!--<p><strong>Metathesaurus Scope</strong><br>
    xx</p>
  <p><strong>Audience</strong><br>
  xx</p>-->
  <p><strong>Update Frequency</strong><br>
    MED-RT is updated monthly.</p>
  <p><strong>Metathesaurus Update Frequency</strong><br>
  MED-RT is a new terminology in the 2018AA release. &nbsp;It will be updated in each release in the future.</p>
  <p><b>Sites Consulted</b></p>		
	<ol>
	  <li>National Cancer Institute [Internet]. Bethesda (MD): National Cancer Institute (US); [cited 2018 Apr 23]. Federal Medication Terminologies; [updated 2018 Apr 02; cited 2018 Apr 23]. Available from: <a href=" https://www.cancer.gov/about-nci/organization/ccct/ctrp">https://www.cancer.gov/about-nci/organization/ccct/ctrp</a>;&nbsp;Introduction to MED-RT as the Replacement for NDF-RTâ„¢:&nbsp;<a href="https://evs.nci.nih.gov/ftp1/MED-RT/Introduction%20to%20MED-RT.pdf">https://evs.nci.nih.gov/ftp1/MED-RT/Introduction%20to%20MED-RT.pdf</a></li>
  </ol>
</div>
